Revenue differences between top-selling small-molecule drugs and biologics in medicare

Vogel, M., Feldman, W. B., Cowan, Z., Rome, B. N., Chandra, A., Kesselheim, A. S. & Wouters, O. J.ORCID logo (2025). Revenue differences between top-selling small-molecule drugs and biologics in medicare. JAMA Health Forum, 6(10). https://doi.org/10.1001/jamahealthforum.2025.4720
Copy
Item Type Article
Copyright holders © 2025 The Author(s)
Departments LSE
DOI 10.1001/jamahealthforum.2025.4720
Date Deposited 29 January 2026
Acceptance Date 7 August 2025
URI https://researchonline.lse.ac.uk/id/eprint/137006

Explore Further

picture_as_pdf
subject
Published Version
Creative Commons: Attribution 4.0
Download

EndNote BibTeX Reference Manager (RIS) Refer Atom Dublin Core JSON Multiline CSV
Export

Downloads
View more statistics